Specification
FORM 2
THE PATENTS ACT, 1970
COMPLETE
SPECIFICATION
SECTION 10 TITLE
"BODY REVIVAL"
APPLICANT
MUNIR KHAN, C/O MOH. AHMAD BAKSH KHAN, RAJ CLASSIC, A WING, FLAT NO 1403/1404, OFF YARI ROAD, VERSOWA, ANDHARI (W), MUMBAI-61, AN INDIAN NATIONAL.
The following specification particularly describes the invention and the manner in which it is to be performed.
FIELD OF INVENTION
This invention relates to body revival.
BACKGROUND OF INVENTION
In the last three decades, treatment of cardiac disorder has led to decline in mortality due to cardiovascular and cerebrovascular complication. Currently, the treatment of cardiovascular disease involves expensive and chronic drug therapy or equally expensive procedures.
OBJECTS OF INVENTION
The primary object of the present invention is to provide body revival which contains several medicinal plants having rejuvenating effect on body.
Another object of the present invention is to provide body revival which has antitumerogenic effect.
Further object of the present invention is to provide body revival which has detoxifying effect against deadly diseases.
Yet another object of the present invention is to provide body revival which is very effective in cardiac disorder, kidney, mouth ulcer, chest infection, B.P.
Still another object of the present invention is to provide body revival which can be used as an
rejuvenator, recuperative and as an adjuvant.
STATEMENT OF INVENTION
According to this invention, there is provided body revival comprising of fruit pulp of Bilv (Aegle marmelos), Rhizome of Vach (Acorus calamus), Roots of Kushtha (Saussurea lappa), Whole plant of Kukranda (Blumea lacera), Leaves of Chukrika (Rumex vericarius), Root of Manjistha (Rubia cordifolia), Seed of Madhufala (Cucumis melo), Bark of Lodhra (Symplocos racemosa) and honey.
DETAIL DESCRIPTION OF THE INVENTION
The present invention discloses body revival comprising of Bilv (Aegle marmelos), Vach (Acorus calamus), Kushtha (Saussurea lappa), Kukranda (Blumea lacera), Chukrika (Rumex vesicarius), Manjistha (Rubia cordifolia), Madhufala (Cucumis melo), Lodhra (Symplocos racemosa) and Honey.
Aegie marmelos • Anntoxident Hepatoprotective Controlling Early Tumor
Events
Acorus Calamus • Hypolipdemic Activity
Saussurea lappa • cancer
Blumea lacera • Leukemia provides Cell Resistance.
Rumex vesicarius • Analgesic Antipyretic, Astringent, Diuretic,
Laxative, Stomachic
Rubia cardifolia • Hypoglycemic Effects Memorary impairment.
Cucumis melo • Hypothyroidism
Symplocos • Obesity in Females Effect on All Female Disorders
Racemosa
Honey • Antibacterial Antioxidant Antitumor Immunomodulatory,
Scavenging Activity of Honey in Endothelial Cell Culture
The fruit of Bilva is the subject of several solar-phallic myths. Hindu physicians regard the unripe or half-ripe fruit as astringent, digestive and stomachic and prescribed it to treat diarrhea and dysentery. It is also used as a remedy in hypochondriasis, melancholia and palpitation of the heart. A major constituent of the fruit is the mucilage and marmelosin a coumarin, in addition to the minor constituents like reducing sugar, essential oils, ascorbic acid and various minerals. Alcoholic and aqueous extracts of the leaves have similar effect as digoxin in amplitude and contractions of the frog's heart, while roots and fruits extracts showed hypoglycaemic activity in albino rats and fruit extract has antiviral activity.
Vach is a semi-aquatic, perennial, armotic herb with creeping rhizomes. The rhizome is horizontal, jointed, somewhat vertically compressed and spongy within. The important constituents are asarone and its β-isomer. The rhizomes are considered to possess anti-spasmodic, and carminative properties, and are used for the treatment of epilepsy and other mental ailments, chronic diarrhea, dysentery, glandular and abdominal tumors. Administration of ethanolic extract Acorus calmus as well as saponins isolated from the extract demonstrated significant hypolipidemic activity, dysentery, glandular and abdominal tumors.
Saussurea is a genus of about 300 species of flowering plants in the family Asteracear, native to cool temperate and arctic regions of Asia, Europe, and North America, with the highest diversity in alpine habitats in the Himalaya and central Asia. Common names include saw-wort and snow lotus, the latter used for a number of high altitude species in central Asia. Saussurea lappa is used as an antiinflammatory drug, and has been shown to inhibit the mRNA expression of iNOS by lipopolysaccharide stimulated macrophages, thus reducing nitric oxide production and reduced several molecular markers of inflammation. Flowers and stems have long been used in traditional Chinese medicine for the treatment of rheumatoid arthritis, cough with cold, stomachache, dysmenorrhea!, and altitude sickness, and have been found to have anti-inflammatory, cardiotonic, anticancer, and antifatigue actions.
Kukranda is an annual herb with a strong odor, distributed throughout the plains of north-west India, up to an altitude of 2,000m.
The fresh herb in flower was submitted to distillation in the usual manner with water, and yielded a light yellow essential oil. Triterpenoid and prenylated phenol glycosides have been isolated from essential oils of Blumea lacera. Blumea lacera is hot, pungent and bitter; antipyretic; good for bronchitis, diseases of the blood, fevers, thirst and burning sensations. The methanolic and aqueous extracts of Blumea lacera showed high cytotoxic activity against k562 cells (Human erythromyeloblastoid leukaemic cells).
Chukrika can grow in semi-shape or no shade. The leaves are aperients, astringent, diuretic and cooling. It is useful in treating heat of the stomach, to ally the pain of toothache and, by its astringent properties, to check nausea. Plants can contain quite high levels of oxalic acid, which is what gives the leaves of many members of this genus an acid-lemon flavor.
Manjistha is found in India, Burma,and SriLanka. If grows wild all over the sub-Himalayan forests. Central India and its west coast and in dry hilly places ascending to 4,000 ft. high. Rubia cordifolia promotes the healing of skin tissues which are damaged by either injury or infection. The capsules made out of its abstracts can be simply taken for general skin problem because it removes toxins from the blood. Since Manjishtha has a remarkable effect on the female reproductive organs, it is useful treating various gynecological problems such as white discharge and irregular menstruation. Rubia cordifolia contains a wide range of antioxidants which can cure various disorders. The herb also exhibits strange free radical scavenging properties against reactive oxygen and nitrogen species as studied by electron paramagnetic resonance spectgroscopy. It significantly diminsied the expression of iNOS gene after 48 hours which plays a major role in neuronal injury during hypoxia/ischemia.
Madhufals is cultivated in West Bengal. The fruit is eaten raw and cooked especially its pulp or juice forms a nutritive, diuretic and cooling drink. Seeds yield sweet edible oil which is useful in painful discharge of urine. It is also useful in eczema. The extract of Cucumis melo L. seed contains Cucurbitacins andisocucurbitacins. Cucurbitacins have anti-tumour activity, offer hepatic protection, anti-hepatitis, improvement of immune function anti-chemocarcinogenesis, an increase of capillary permeability, and induced vomiting.
Lodhra or symplocos racemosa grows abundantly in the plains and lower hills throughout North and East India, ascending in the Himalayas up to an elevation of 1,400m. Three alkaloids, viz. loturine, loturidine and colloturine have so far been isolated. The astringent bark is given for the treatment of diarrhea, dysentery and liver complaints. It is recommended in the treatment of menorrhagia and other uterine disorders. The plant have immunomodulatory activities both in animals and in humans.
Honey is a mixture of sugars and other compounds. With respect to carbrohydrates, honey is mainly fructose and glucose. Honey's remaining carbohydrates include maltose, sucrose, and other complex carbohydrates. Honey contains tarce amounts of several vitamins and minerals. As with all nutritive sweeteners, honey is mostly sugars and is not a significant source of vitamins or minerals.
Honey also contains tiny amounts of several compounds to function as antioxidants, including chrysin, pinobanksin, vitamin C, catalase, and pinocembrin. It boost immunity, promote healing of cuts and burns, remedy for sore throats, colds, hangover, sleeplessness, stomach upsets. Honey contains natural minerals and vitamins which help the metabolizing of undesirable cholesterol and fatty acid on the organs and tissues into the system, hence preventing obesity and promoting better health. Honey has been shown to be an effective in conjunctivitis.
The following may be taken as an example without restricting scope of the invention to the same.
An exemplary embodiment of herbal formulation (Body Revival) of the present invention is as follows :-
Sr. No Ingredients as Std. Mg Used in Used in
(Common/Botanical name bulk batch bulk batch
NLT 10% NMT 12%
1 Bilv (Aegle marmelos) Ay.Ph 150 160 mg 168mg
2 Vach (Acorus calamus) Ay.Ph 175 192.5mg 196mg
3 Kushtha (Saussurea calamus) Ay.Ph 325 357.5mg 364mg
4 Kukranda (Blumea lacera) Ay.Ph 115 126.5mg 128.8mg
5 Amlavet(Rumex vesicarius) Ay.Ph 240 264mg 268.8mg
6 Manjistha (Rubia cordifolia) Ay.Ph 200 220mg 224mg
7 Madhufala (Cucumis melo) Ay.Ph 200 220mg 224mg
8 Lodhra Ay.Ph 095 104.5mg 106:4mg (Symplocos racemosa)
9 Preservative LP qs
10 Honey LP qs
Results
Parameters Specifications
Description Dark brown viscous liquid containing herbs
Odour Characterstic
pH Between 5-7
Arsenic Content <3ppm
Lead Content <10pm
Cadmium Content
Documents
Orders
| Section |
Controller |
Decision Date |
|
|
|
Application Documents
| # |
Name |
Date |
| 1 |
540-MUM-2011-FORM 4(ii) [25-01-2018(online)].pdf |
2018-01-25 |
| 1 |
540-MUM-2011-US(14)-ExtendedHearingNotice-(HearingDate-15-01-2021).pdf |
2021-10-03 |
| 2 |
540-mum-2011-OTHERS [17-04-2018(online)].pdf |
2018-04-17 |
| 2 |
540-MUM-2011-US(14)-ExtendedHearingNotice-(HearingDate-25-11-2020).pdf |
2021-10-03 |
| 3 |
540-MUM-2011-US(14)-HearingNotice-(HearingDate-23-11-2020).pdf |
2021-10-03 |
| 3 |
540-MUM-2011-FORM 3 [17-04-2018(online)].pdf |
2018-04-17 |
| 4 |
540-MUM-2011-HEARING LETTER-16-12-2020 .pdf |
2020-12-16 |
| 4 |
540-mum-2011-FER_SER_REPLY [17-04-2018(online)].pdf |
2018-04-17 |
| 5 |
540-MUM-2011-Returned Speed Post Hearing Letter dated 16-12-2020.pdf |
2020-12-16 |
| 5 |
540-mum-2011-CLAIMS [17-04-2018(online)].pdf |
2018-04-17 |
| 6 |
540-MUM-2011-Written submissions and relevant documents [25-11-2020(online)].pdf |
2020-11-25 |
| 6 |
540-MUM-2011-FORM 5(29-2-2012).pdf |
2018-08-10 |
| 7 |
540-mum-2011-form 2.pdf |
2018-08-10 |
| 7 |
540-MUM-2011-ABSTRACT(29-2-2012).pdf |
2018-08-10 |
| 8 |
540-mum-2011-form 2(title page).pdf |
2018-08-10 |
| 8 |
540-MUM-2011-CLAIMS(29-2-2012).pdf |
2018-08-10 |
| 9 |
540-MUM-2011-CORRESPONDENCE(16-9-2014).pdf |
2018-08-10 |
| 9 |
540-MUM-2011-FORM 2(TITLE PAGE)-(29-2-2012).pdf |
2018-08-10 |
| 10 |
540-MUM-2011-CORRESPONDENCE(23-9-2013).pdf |
2018-08-10 |
| 10 |
540-MUM-2011-FORM 2(29-2-2012).pdf |
2018-08-10 |
| 11 |
540-MUM-2011-CORRESPONDENCE(27-2-2013).pdf |
2018-08-10 |
| 11 |
540-MUM-2011-FORM 18(27-2-2013).pdf |
2018-08-10 |
| 12 |
540-MUM-2011-CORRESPONDENCE(29-2-2012).pdf |
2018-08-10 |
| 12 |
540-mum-2011-form 1.pdf |
2018-08-10 |
| 13 |
540-mum-2011-correspondence.pdf |
2018-08-10 |
| 13 |
540-MUM-2011-FER.pdf |
2018-08-10 |
| 14 |
540-MUM-2011-DESCRIPTION(COMPLETE)-(29-2-2012).pdf |
2018-08-10 |
| 14 |
540-mum-2011-description(provisional).pdf |
2018-08-10 |
| 15 |
540-MUM-2011-DESCRIPTION(COMPLETE)-(29-2-2012).pdf |
2018-08-10 |
| 15 |
540-mum-2011-description(provisional).pdf |
2018-08-10 |
| 16 |
540-mum-2011-correspondence.pdf |
2018-08-10 |
| 16 |
540-MUM-2011-FER.pdf |
2018-08-10 |
| 17 |
540-mum-2011-form 1.pdf |
2018-08-10 |
| 17 |
540-MUM-2011-CORRESPONDENCE(29-2-2012).pdf |
2018-08-10 |
| 18 |
540-MUM-2011-CORRESPONDENCE(27-2-2013).pdf |
2018-08-10 |
| 18 |
540-MUM-2011-FORM 18(27-2-2013).pdf |
2018-08-10 |
| 19 |
540-MUM-2011-CORRESPONDENCE(23-9-2013).pdf |
2018-08-10 |
| 19 |
540-MUM-2011-FORM 2(29-2-2012).pdf |
2018-08-10 |
| 20 |
540-MUM-2011-CORRESPONDENCE(16-9-2014).pdf |
2018-08-10 |
| 20 |
540-MUM-2011-FORM 2(TITLE PAGE)-(29-2-2012).pdf |
2018-08-10 |
| 21 |
540-MUM-2011-CLAIMS(29-2-2012).pdf |
2018-08-10 |
| 21 |
540-mum-2011-form 2(title page).pdf |
2018-08-10 |
| 22 |
540-MUM-2011-ABSTRACT(29-2-2012).pdf |
2018-08-10 |
| 22 |
540-mum-2011-form 2.pdf |
2018-08-10 |
| 23 |
540-MUM-2011-FORM 5(29-2-2012).pdf |
2018-08-10 |
| 23 |
540-MUM-2011-Written submissions and relevant documents [25-11-2020(online)].pdf |
2020-11-25 |
| 24 |
540-mum-2011-CLAIMS [17-04-2018(online)].pdf |
2018-04-17 |
| 24 |
540-MUM-2011-Returned Speed Post Hearing Letter dated 16-12-2020.pdf |
2020-12-16 |
| 25 |
540-MUM-2011-HEARING LETTER-16-12-2020 .pdf |
2020-12-16 |
| 25 |
540-mum-2011-FER_SER_REPLY [17-04-2018(online)].pdf |
2018-04-17 |
| 26 |
540-MUM-2011-US(14)-HearingNotice-(HearingDate-23-11-2020).pdf |
2021-10-03 |
| 26 |
540-MUM-2011-FORM 3 [17-04-2018(online)].pdf |
2018-04-17 |
| 27 |
540-MUM-2011-US(14)-ExtendedHearingNotice-(HearingDate-25-11-2020).pdf |
2021-10-03 |
| 27 |
540-mum-2011-OTHERS [17-04-2018(online)].pdf |
2018-04-17 |
| 28 |
540-MUM-2011-US(14)-ExtendedHearingNotice-(HearingDate-15-01-2021).pdf |
2021-10-03 |
| 28 |
540-MUM-2011-FORM 4(ii) [25-01-2018(online)].pdf |
2018-01-25 |
Search Strategy
| 1 |
SearchStrategy540_25-07-2017.pdf |